Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

598
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
598
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

49.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

823
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
823
Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.8K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omics body-fluid biomarkers in immunoglobulin a nephropathy: Analytical Validation, standardization, and clinical chemistry translation of diagnostic and prognostic Analytes.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Corrigendum to "Multi-omics biomarker in adrenocortical carcinoma: a clinical-chemistry perspective" [Clin. Chim. Acta 590 (2026) 121103].

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Multi-omics biomarker in adrenocortical carcinoma: a clinical-chemistry perspective.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Ameloblastic fibroma and BRAF V600E immunohistochemistry staining pattern: case report and review of a rare entity.

International journal of oral and maxillofacial surgery·2025
Same author

Dosimetric evaluation and gradient analysis of various MLC leaf-width effects in external beam radiation therapy: TrueBeam Vs Halcyon.

Radiography (London, England : 1995)·2024
Same author

Transcriptomic profiling reveals differential cellular response to copper oxide nanoparticles and polystyrene nanoplastics in perfused human placenta.

Environment international·2023

Related Experiment Video

Updated: Jan 4, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.8K

Current concepts in HIV pathogenesis and treatment.

G Gupta1

  • 1Division of Infectious Diseases, University of California, Irvine Medical Center, USA.

Journal of the California Dental Association
|April 28, 2001
PubMed
Summary

Significant progress has been made in treating human immunodeficiency virus (HIV) infection, leading to lower death rates. However, new HIV infections continue annually, highlighting ongoing challenges in disease control.

Area of Science:

  • Virology and Immunology
  • Infectious Diseases
  • Public Health

Background:

  • Advances in understanding and treating human immunodeficiency virus (HIV) have been substantial.
  • Introduction of protease inhibitors has significantly reduced HIV-related mortality.
  • Despite progress, approximately 40,000 new HIV infections occur annually in the U.S.

Purpose of the Study:

  • To review recent advancements in HIV pathogenesis.
  • To discuss novel treatment strategies for HIV.
  • To identify current limitations in managing HIV infection.

Main Methods:

  • Literature review of recent studies on HIV pathogenesis.
  • Analysis of current and emerging HIV treatment modalities.
  • Discussion of epidemiological data on new HIV infections.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.3K
Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

12.9K

Related Experiment Videos

Last Updated: Jan 4, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.8K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.3K
Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

12.9K

Main Results:

  • Significant decline in HIV-related death rates observed.
  • Continued high incidence of new HIV infections despite therapeutic advances.
  • Identification of specific challenges in comprehensive HIV control.

Conclusions:

  • While HIV treatment has improved, complete eradication remains elusive.
  • Ongoing research into pathogenesis and treatment is crucial.
  • Public health strategies are needed to address persistent new infections.